Akoya Biosciences

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

Analysts expect Ford Motor Co. (NYSE: F) to post quarterly earnings at 33 cents per share on revenue of $43.25 billion after the closing bell. Ford shares fell 0.7% to $10.09 in after-hours trading.

News

Upgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

AKYA

CNOB

GLBE

This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

GoldmanSachs.Shutterstock

Price Target

ARTV

LUNR

QTRX

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday

Brown & Brown Inc. (NYSE- BRO)

Downgrades

AZEK

This Brown &amp; Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Akoya Biosciences Inc

Press Releases

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

Earnings

Health Care

General

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

CMBM

CSCO

DOMO

FTSW

ICLR

ILMN

OPTN

PRAH

SFSF

SHYF

SLRN

YDLE

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

Codexis

Champions Oncology

Harvard Bioscience

Lifecore Biomedical

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Piper Sandler

Stephens & Co.

Craig-Hallum

Canaccord Genuity

Morgan Stanley

Comments

Akoya Biosciences

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell